生物医药高技术是新世纪技术革命的主角 ,近年来生物医药高技术的发展对药物的开发和研制过程产生了极大的冲击 ,同时也为生物学、医学和药学的发展带来了空前的机遇。本文中提出生物医药高技术的发展应适时引入风险投资基金 ,并对生物医药高技术领域内引入风险投资基金的必要性、可行性及其运作规则进行了探讨 High-tech biomedicine is the protagonist of the technological revolution in the new century. In recent years, the development of high-tech biomedicine has had a tremendous impact on the process of drug development and development. It has also brought unprecedented challenges to the development of biology, medicine and pharmacy opportunity. In this paper, it is proposed that the development of high-tech biomedicine should be timely introduced into venture capital funds, and the necessity, feasibility and operational rules for introducing venture capital funds into biomedical high-tech fields are discussed